Nripen Singh

Nripen Singh has a diverse range of work experience in the biopharmaceutical and research fields. Their most recent position is Vice President of Process/Analytical/Quality Control at Passage Bio, where they have been employed since 2021. Prior to that, they worked as an Executive Director of Technical Development at the same company.

Before joining Passage Bio, Singh held positions at Voyager Therapeutics, Inc. as the Senior Director of Biopharmaceutical Development and Director of Biopharmaceutical Development. Nripen also worked at Bristol-Myers Squibb, where they held roles such as Associate Director of MS&T Downstream, Manager of Process Development Downstream, and Senior Scientist of Process Development Downstream.

Singh's earlier career included roles at MilliporeSigma as a Senior Research Scientist and Research Scientist III, Lynntech, Inc. as a Research Scientist, and the University of Delaware as a Postdoctoral Researcher in Chemical Engineering. Nripen also worked as a Visiting Scientist at the University of Duisburg-Essen and as a Research Assistant at Clemson University, where they completed their PhD. Additionally, they served as an Adjunct Professor at University College Dublin.

Nripen Singh completed a BE degree in Chemical Engineering from Panjab University from 1998 to 2002. Later, from 2002 to 2007, they pursued a PhD in Chemical Engineering from Clemson University. Recently, from 2020 to 2021, they attended the Harvard Business School Executive Education program, completing the Executive MBA Alternative - PLD31.